4.4 Article

Loss of the Batten Disease Gene CLN3 Prevents Exit from the TGN of the Mannose 6-Phosphate Receptor

Journal

TRAFFIC
Volume 9, Issue 11, Pages 1905-1914

Publisher

WILEY-BLACKWELL
DOI: 10.1111/j.1600-0854.2008.00807.x

Keywords

Batten; CLN3; Golgi; mannose 6-phosphate; neuronal ceroid lipofuscinosis; receptor

Categories

Funding

  1. Medical Research Council UK
  2. Children's Brain Diseases Foundation USA
  3. European Commission [LSHM-CT-2003-503051]
  4. MRC [MC_U122665003, G0700750] Funding Source: UKRI
  5. Medical Research Council [G0700750, MC_U122665003] Funding Source: researchfish

Ask authors/readers for more resources

The neuronal ceroid lipofuscinoses (NCLs, Batten disease) are a group of inherited childhood-onset neurodegenerative disorders characterized by the lysosomal accumulation of undigested material within cells. To understand this dysfunction, we analysed trafficking of the cation-independent mannose 6-phosphate receptor (CI-MPR), which delivers the digestive enzymes to lysosomes. A common form of NCL is caused by mutations in CLN3, a multipass transmembrane protein of unknown function. We report that ablation of CLN3 causes accumulation of CI-MPR in the trans Golgi network, reflecting a 50% reduction in exit. This CI-MPR trafficking defect is accompanied by a fall in maturation and cellular activity of lysosomal cathepsins. CLN3 is therefore essential for trafficking along the route needed for delivery of lysosomal enzymes, and its loss thereby contributes to and may explain the lysosomal dysfunction underlying Batten disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available